Strategy slides after bitcoin briefly dips below crypto firm’s key breakeven level

Strategy slides after bitcoin briefly dips below crypto firm’s key breakeven level


Michael Saylor, chairman of MicroStrategy, speaks at the Bitcoin 2024 conference in Nashville, Tennessee, on July 26, 2024.
Bloomberg | Bloomberg | Getty Images

Strategy plunged 8% on Monday after bitcoin dipped below the cryptocurrency treasury company’s average purchase price per token.  

Bitcoin traded at about $74,500 at its bottom on Monday – its lowest price since last April.

That’s slightly below Strategy’s average purchase price of $76,052 per bitcoin, according to its regulatory filing dated Feb. 2, raising concerns that the Michael Saylor-led firm could be underwater if the digital currency continues to slide. The company holds roughly $56 billion in bitcoin, its website shows.

The pullback in shares comes as bitcoin has shed 11% over the past five days, largely due to mounting geopolitical concerns and expectations of a monetary policy shift in the U.S. 

Last week, investors rotated out of risk-on assets across global markets, including cryptocurrencies, as tensions flared between President Donald Trump and European leaders over the U.S.’ Greenland gambit. On Friday, President Trump endorsed Kevin Warsh as his pick for Federal Reserve chair, leading investors to assume even more cautious positions. 

A series of forced liquidations also amplified bitcoin’s plunge. More than $2 billion of long and short positions linked to the asset have been liquidated since Thursday, Coinglass data shows.



Source

Stocks making the biggest moves midday: Novo Nordisk, Palantir, AES, Rocket and more
Finance

Stocks making the biggest moves midday: Novo Nordisk, Palantir, AES, Rocket and more

Check out the companies making headlines before the bell: Novo Nordisk — The maker of obesity drug Wegovy’s U.S. stock fell about 13% after unexpectedly warning that fiscal 2026 sales will be hurt by lower drug prices in the U.S. even as it anticipates more patients will use its popular GLP-1 drug. Novo Nordisk said […]

Read More
Rocket Companies shares jump 6% after CEO says mortgage loan volume is surging
Finance

Rocket Companies shares jump 6% after CEO says mortgage loan volume is surging

In this article RKT Follow your favorite stocksCREATE FREE ACCOUNT watch now VIDEO8:4108:41 Rocket Companies CEO: On track to produce the highest mortgage loan production in 4 years Squawk Box Rocket Companies shares jumped on Tuesday after CEO Varun Krishna told CNBC the company was writing a larger amount of mortgage loans. “We’re getting ready […]

Read More
Stocks making the biggest moves premarket: Palantir Technologies, Merck, Pfizer & more
Finance

Stocks making the biggest moves premarket: Palantir Technologies, Merck, Pfizer & more

Check out the companies making headlines before the bell: Palantir — The stock jumped 11% following the AI-powered software provider’s fourth-quarter earnings beat . Palantir reported adjusted earnings of 25 cents per share, versus the 23 cents expected from analysts polled by LSEG. Revenue was $1.41 billion, topping the $1.33 billion consensus estimate. Merck — […]

Read More